Weight Loss Drugs Market, By Type, By Dosage Form, By Application, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Weight Loss Drugs Market size was valued at US$ 54,503.22 Million in 2024, expanding at a CAGR of 19.29% from 2025 to 2032.

The Weight Loss Drugs Market is the global industry that develops, makes, and sells pharmaceutical products to help people lose weight. These drugs operate in different ways, like suppressing appetite, blocking fat absorption, or boosting metabolism to manage obesity and overweight issues. The market includes prescription medications, over-the-counter products, and new therapies aimed at tackling the rising rates of obesity-related health problems around the world. The market is growing due to increased awareness of the health risks associated with obesity, more sedentary lifestyles, and a higher demand for effective and safe weight management solutions.

Weight Loss Drugs Market- Market Dynamics

Rising awareness about health risks associated with obesity

With the rise of public health campaigns, increased media attention, and ongoing medical research shining a light on the serious health risks associated with obesity like type 2 diabetes, heart disease, certain cancers, and breathing issues more people are starting to realize just how important it is to manage their weight. The World Health Organization (WHO) reports that since 1975, the global rate of obesity has nearly tripled, with over 1.9 billion adults considered overweight in 2023, and more than 650 million of those classified as obese. This growing awareness is pushing individuals to look for effective treatment options, including weight loss medications, to help mitigate these health risks. Consequently, healthcare providers are increasingly suggesting pharmacological treatments alongside lifestyle changes. This growing consciousness about obesity related complications is significantly boosting the demand for weight loss drugs worldwide, prompting pharmaceutical companies to create safer and more effective options to address this pressing need.

For Instance,

In January 2024, Novo Nordisk expanded the availability of its flagship weight loss drug, Wegovy (semaglutide), to multiple new international markets. This expansion addresses the rising global demand for effective obesity treatments and reinforces Novo Nordisk's leadership in the weight loss drugs sector, aiming to help more patients manage obesity and related health risks worldwide.

Weight Loss Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.29% over the forecast period (2025-2032)

Based on type segmentation, prescription drugs were predicted to show maximum market share in the year 2024

Based on dosage form segmentation, injections was the leading dosage form in 2024

Based on application segmentation, appetite suppression was the leading application in 2024

Based on distribution channel segmentation, retail pharmacy was the leading distribution channels in 2024

On the basis of region, North America was the leading revenue generator in 2024

Weight Loss Drugs Market- Segmentation Analysis:

The global weight loss drugs market is segmented on the basis of type, dosage form, application, distribution channel, and region.

The market is divided into two categories based on type: Over-the-counter drugs (OTC) and prescription drugs. The Prescription Drugs segment dominates the Weight Loss Drugs Market due to their proven effectiveness and safety profile, which require medical supervision. These drugs often involve advanced formulations that specifically target metabolic pathways, appetite regulation, or fat absorption, making them more reliable for treating moderate to severe obesity. Physicians prefer prescribing these medications because they provide clinically validated results and are supported by rigorous regulatory approvals. Additionally, the growing prevalence of obesity-related health complications is driving increased physician recommendation of prescription weight loss drugs.

The market is divided into three categories based on application: appetite suppression and fat blocking and others. The appetite suppression sector dominates the market and Appetite suppressants work by targeting the central nervous system to reduce feelings of hunger and control cravings, which helps individuals consume fewer calories and promotes sustained weight loss. This direct approach to managing food intake makes appetite suppressants a preferred choice for both healthcare providers and patients. Moreover, recent advancements in drug formulations have enhanced their safety profiles and effectiveness, increasing patient adherence and satisfaction. With obesity rates continuing to rise globally, appetite suppressants remain at the forefront of pharmacological weight management, driving significant market growth and innovation.

Weight Loss Drugs Market- Geographical Insights

North America dominates the global weight loss drugs market during the forecast period in 2024.

North America is dominating region in the weight loss drugs market, accounting for the largest market share due to its high prevalence of obesity, strong healthcare infrastructure, and widespread access to advanced medications. The United States, in particular, leads the region with a significant portion of the adult population classified as overweight or obese. Additionally, the early approval and commercial success of weight loss drugs such as Wegovy (Novo Nordisk) and Zepbound (Eli Lilly) have boosted market growth. Favourable reimbursement policies, growing awareness about obesity-related health risks, and active government support further contribute to North America's market dominance.

Asia Pacific is estimated to register the highest CAGR in the weight loss drugs market during the forecast period in 2024.

Asia-Pacific region is emerging as the fastest-growing market, driven by rapid urbanization, sedentary lifestyles, and dietary changes leading to a surge in obesity rates. Countries like China, India, and South Korea are experiencing a sharp rise in obesity-related diseases such as diabetes and cardiovascular disorders. Alongside this, increasing disposable incomes, improved access to healthcare, and growing acceptance of pharmaceutical treatments for weight loss are accelerating demand. Moreover, expanding healthcare initiatives and government-backed public health programs aimed at obesity prevention are supporting the market's rapid expansion across Asia-Pacific.

Weight Loss Drugs Market- Competitive Landscape:

The weight loss drugs market is highly competitive and rapidly evolving, driven by a mix of pharmaceutical giants, emerging biotech firms, and growing R&D investments in obesity treatment. Leading players such as Novo Nordisk, Eli Lilly, Pfizer, Johnson & Johnson, and GlaxoSmithKline are at the forefront, competing through innovation, clinical trial advancements, and global market expansion.

With its popular medication Wegovy (semaglutide), which has demonstrated excellent clinical outcomes and great demand worldwide, Novo Nordisk presently holds a dominant market share. With Zepbound (tirzepatide), Eli Lilly has swiftly become a formidable competitor, providing dual-action advantages for type 2 diabetes and weight loss. To keep up with the increasing demand, both businesses are making significant investments in manufacturing capacity and entering new markets. To penetrate or improve their positions in this rapidly expanding market, Pfizer and GSK are concentrating on pipeline research and strategic partnerships. Smaller biotech businesses are also making an appearance with customized obesity treatments and innovative methods of action.

The market is witnessing increased competition in terms of efficacy, safety profiles, dosing convenience, and long-term outcomes, with companies also pursuing partnerships, licensing deals, and acquisitions to expand their reach. As obesity rates continue to climb globally, the competitive intensity in the weight loss drugs market is expected to remain strong, fostering ongoing innovation and commercial activity.

Recent Developments:

In June 2025, Eli Lilly announced a strategic collaboration with Amazon Pharmacy to distribute its weight loss drug Zepbound (tirzepatide) directly to consumers. The move aims to improve patient access and convenience, while expanding Eli Lilly's digital health footprint in the obesity treatment space. This partnership supports broader adoption amid rising demand for weight management therapies.

In April 2025, Novo Nordisk acquired Emisphere Technologies, a company known for oral drug delivery systems. This acquisition is intended to improve oral formulations of semaglutide, the active ingredient in Wegovy, enhancing patient compliance and accessibility. It strengthens Novo Nordisk's innovation pipeline and supports its strategy to lead in both injectable and oral weight loss therapies.

In January 2025, Johnson & Johnson entered into a co-development partnership with a U.S.-based biotech firm to create dual-acting metabolic modulators for obesity management. The collaboration focuses on developing next-generation drugs that offer safer, long-term weight loss. This move reflects J&J's renewed strategic interest in addressing global obesity and metabolic disorders.

In October 2024, GlaxoSmithKline (GSK) launched Phase 2 clinical trials for a novel appetite suppressant targeting central nervous system pathways. This innovation is part of GSK's broader goal to expand its metabolic health portfolio with first-in-class treatments. The company aims to develop therapies that offer high efficacy with improved patient compliance and minimal side effects.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL WEIGHT LOSS DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eli Lilly and Company
Amgen Inc.
AstraZeneca
F. Hoffmann-La Roche Ltd (Roche Holding AG)
GlaxoSmithKline plc
Ionis Pharmaceuticals, Inc.
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Rhythm Pharmaceuticals, Inc.
Sanofi S.A.
Structure Therapeutics Inc.
Takeda Pharmaceutical Company Limited
VIVUS, Inc.
Zafgen, Inc.
Eisai Co., Ltd.
Boehringer Ingelheim International GmbH
Currax Pharmaceuticals LLC
Others

GLOBAL WEIGHT LOSS DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Over-the-counter drugs (OTC)
Prescription Drugs

GLOBAL WEIGHT LOSS DRUGS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

Capsules
Injections
Liquids
Tablets

GLOBAL WEIGHT LOSS DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Appetite Suppression
Fat Blocking
Others

GLOBAL WEIGHT LOSS DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Online Pharmacy
Hospital Pharmacy
Retail Pharmacy

GLOBAL WEIGHT LOSS DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5439

1. Weight Loss Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Weight Loss Drugs Market Snippet by Type
- 2.1.2. Weight Loss Drugs Market Snippet by Dosage Form
- 2.1.3. Weight Loss Drugs Market Snippet by Application
- 2.1.4. Weight Loss Drugs Market Snippet by Distribution Channel
- 2.1.5. Weight Loss Drugs Market Snippet by Country
- 2.1.6. Weight Loss Drugs Market Snippet by Region
2.2. Competitive Insights

3. Weight Loss Drugs Key Market Trends

3.1. Weight Loss Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Weight Loss Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Weight Loss Drugs Market Opportunities
3.4. Weight Loss Drugs Market Future Trends

4. Weight Loss Drugs Industry Study

4.1. PESTEL Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Weight Loss Drugs Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Weight Loss Drugs Market Landscape

6.1. Weight Loss Drugs Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Weight Loss Drugs Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Over-the-counter drugs (OTC)
- 7.1.3. Prescription Drugs

8. Weight Loss Drugs Market - By Dosage Form

8.1. Overview
- 8.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
- 8.1.2. Capsules
- 8.1.3. Injections
- 8.1.4. Liquids
- 8.1.5. Tablets

9. Weight Loss Drugs Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Appetite Suppression
- 9.1.3. Fat Blocking
- 9.1.4. Others

10. Weight Loss Drugs Market - By Distribution Channel

10.1. Overview
- 10.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
- 10.1.2. Online Pharmacy
- 10.1.3. Hospital Pharmacy
- 10.1.4. Retail Pharmacy

11. Weight Loss Drugs Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Weight Loss Drugs Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Weight Loss Drugs Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Weight Loss Drugs Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Weight Loss Drugs Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Weight Loss Drugs Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Weight Loss Drugs Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Eli Lilly and Company
- 12.2.2. Amgen Inc.
- 12.2.3. AstraZeneca
- 12.2.4. F. Hoffmann-La Roche Ltd (Roche Holding AG)
- 12.2.5. GlaxoSmithKline plc
- 12.2.6. Ionis Pharmaceuticals, Inc.
- 12.2.7. Johnson & Johnson
- 12.2.8. Merck & Co., Inc.
- 12.2.9. Novartis AG
- 12.2.10. Teva Pharmaceutical Industries Ltd.
- 12.2.11. Pfizer Inc.
- 12.2.12. Rhythm Pharmaceuticals, Inc.
- 12.2.13. Sanofi S.A.
- 12.2.14. Structure Therapeutics Inc.
- 12.2.15. Takeda Pharmaceutical Company Limited
- 12.2.16. VIVUS, Inc.
- 12.2.17. Zafgen, Inc.
- 12.2.18. Eisai Co., Ltd.
- 12.2.19. Boehringer Ingelheim International GmbH
- 12.2.20. Currax Pharmaceuticals LLC
- 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us